SPOT ON mate the board members are clowns .

First 140 Last

Share
Profile

Follow
collipop

8,231 Posts.

341

22/03/24

11:24

Post #: 73010472
Share

Originally posted by Gollada: ↑

they don't care and the worry is they are capable of spending 2 more years drilling shallow holes at a snail's pace without any remorse or sense of responsibility towards the SHs.

the rain might delay the 1st drilling of the year. quarter 1 is almost behind us. when the ground is ready for drilling will they try and drill two different locations to make up for the lost time? I doubt. They will be more than happy to use the rain as an excuse.

one whole quarter gone with no work, but I am sure they are getting paid. and if they hit something accidentally and things turn around they have secured payback via performance rights.

It is raining around Tennant Creek so why aren't they drilling at Mt Remarkable? They had good strikes there. they did some helicopter surveys in 2021 and were going to focus on Mt Remarkable in 2022 ( see 18th Feb 2022 Announcement). but it fell off the radar just like the HPA process enhancement (see 20th Sep 2022 announcement) and the proposed buyback ( 10th July 2023 announcement).

there was still a fair bit of activity and announcements in 2022. Since 2023 it's gone so quiet.

I am beginning to get worried, if they even have a short and long-term strategy. it seems they keep jumping from one project to another at will. They lack focus and clarity. and they never bother to tell the SH why they are moving on to another project all of a sudden.

between my 2 accounts, I have around 10 million shares. we need to start doing the maths to see if we have enough to vote them out. the sooner the better.

Expand

SPOT ON mate the board members are clowns .

KRR Price at posting: 1.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 18 more messages in this thread...

First 140 Last

Add KRR (ASX) to my watchlist

(20min delay)
Last 0.9¢		Change 0.000(0.00%)		Mkt cap ! $13.75M

Open	High	Low	Value	Volume
0.9¢	0.9¢	0.9¢	$10.01K	1.112M

Buyers (Bids)

No.	Vol.	Price($)
1	624224	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	2813630	8

View Market Depth

No.	Vol.	Price($)
1	624224	0.009
16	30340515	0.008
4	3219627	0.007
8	8323695	0.006
13	8236895	0.005

Price($)	Vol.	No.
0.010	2813630	8
0.011	1900000	6
0.012	938734	8
0.013	696263	4
0.014	591063	5

Last trade - 11.44am 07/10/2024 (20 minute delay)

KRR (ASX) Chart

SPOT ON mate the board members are clowns .

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

SPOT ON mate the board members are clowns .

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News